FBLG Q3 2025 Earnings — FibroBiologics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

FBLGFibroBiologics, Inc. Common Stock

$17M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$231,000

Operating Income

-$5M

Net Income

-$6M

EPS (Diluted)

$-0.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$704,000

Balance Sheet

Total Assets

$9M

Total Liabilities

$9M

Stockholders' Equity

$125,000

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$231,000	$0	—
Operating Income	-$5M	-$3M	-50.3%
Net Income	-$6M	-$500,000	-1055.6%